Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Diplopia | x | x | ||
Dizziness | x | x | ||
Drowsiness | x | x | ||
Headache | x | x | ||
Haemorrhage | x | |||
Hyperventilation | x | x | ||
Inflammation | x | |||
Nausea | x | x | ||
Pain | x | x | ||
Tachycardia | x | x | ||
Muscular weakness | x | |||
Excitement | x | x | ||
Muscle necrosis | x | |||
Vision blurred | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |